SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000220
Filing Date
2021-11-08
Accepted
2021-11-08 08:00:00
Documents
20
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20211108.htm   iXBRL 8-K 40750
2 EX-99.1 a3q2021earningspressrele.htm EX-99.1 20096
6 GRAPHIC a3q2021earningspressrele001.jpg GRAPHIC 242603
7 GRAPHIC a3q2021earningspressrele002.jpg GRAPHIC 260339
8 GRAPHIC a3q2021earningspressrele003.jpg GRAPHIC 327529
9 GRAPHIC a3q2021earningspressrele004.jpg GRAPHIC 339212
10 GRAPHIC a3q2021earningspressrele005.jpg GRAPHIC 268108
11 GRAPHIC a3q2021earningspressrele006.jpg GRAPHIC 132884
12 GRAPHIC a3q2021earningspressrele007.jpg GRAPHIC 103328
  Complete submission text file 0001485003-21-000220.txt   2516875

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20211108.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20211108_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20211108_pre.xml EX-101.PRE 13190
13 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20211108_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211386553
SIC: 2834 Pharmaceutical Preparations